Cara Therapeutics Inc (CARA)

Apr 23, 2025

(CARA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 23, 2025

Apr 23, 2025

Form 8-KCurrent report - ADVFN

Apr 23, 2025

Apr 22, 2025

Cara Therapeutics (NASDAQ:CARA) Coverage Initiated at StockNews.com - Defense World

Apr 22, 2025

Apr 15, 2025

Tvardi Therapeutics Closes Merger with Cara Therapeutics - citybiz

Apr 15, 2025

Apr 15, 2025

Cara Therapeutics Inc Stock Price, Quotes and Forecasts - Benzinga

Apr 15, 2025

Apr 15, 2025

Cara Therapeutics Completes Merger with Tvardi Therapeutics - TipRanks

Apr 15, 2025

Apr 15, 2025

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - Benzinga

Apr 15, 2025

Apr 15, 2025

Cara Therapeutics announces 1-for-3 reverse stock split related to Tvardi merger - Hartford Business Journal

Apr 15, 2025

Apr 14, 2025

Cara Therapeutics (CARA) to Rebrand and Trade as Tvardi Therapeu - GuruFocus

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Announces 1-for-3 Reverse Stock Split - citybiz

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars - NewsBreak: Local News & Alerts

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics announces 1-for-3 reverse stock split By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Announces 1-For-3 Reverse Stock Split - marketscreener.com

Apr 14, 2025

Apr 14, 2025

Cara Approves Reverse Split in Connection With Tvardi Merger - marketscreener.com

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics announces 1-for-3 reverse stock split - Investing.com

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Conne - GuruFocus

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics | CARA Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in - GlobeNewswire

Apr 14, 2025

Apr 14, 2025

Major Transformation: Cara Therapeutics Unveils 1:3 Split Plan Before Tvardi Merger - Stock Titan

Apr 14, 2025

Apr 14, 2025

Cara Therapeutics (NASDAQ:CARA) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 14, 2025

Apr 13, 2025

Cara Therapeutics CEO Posner sells shares worth $1,755 - MSN

Apr 13, 2025

Apr 11, 2025

Cara Therapeutics Announces Merger with Tvardi Therapeutics - TipRanks

Apr 11, 2025

Apr 09, 2025

Cara Therapeutics, Inc. (NASDAQ:CARA) Receives Average Recommendation of “Hold” from Analysts - Defense World

Apr 09, 2025

Apr 01, 2025

Cara Therapeutics approves merger and stock plans - Investing.com India

Apr 01, 2025

Apr 01, 2025

Cara Therapeutics approves merger and stock plans By Investing.com - Investing.com India

Apr 01, 2025

Mar 31, 2025

Shareholders sue to block Stamford-based Cara Therapeutics’ proposed merger with Houston biopharma firm - Hartford Business Journal

Mar 31, 2025

Mar 29, 2025

StockNews.com Begins Coverage on Cara Therapeutics (NASDAQ:CARA) - Defense World

Mar 29, 2025

Mar 27, 2025

How To Trade (CARA) - Stock Traders Daily

Mar 27, 2025

Mar 24, 2025

Cara Therapeutics announces merger with Tvardi Therapeutics By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Cara Therapeutics announces merger with Tvardi Therapeutics - Investing.com

Mar 24, 2025

Mar 21, 2025

Cara Therapeutics (NASDAQ:CARA) Now Covered by Analysts at StockNews.com - Defense World

Mar 21, 2025

Mar 20, 2025

Cannabis Stock Gainers And Losers From March 20, 2025 - Benzinga

Mar 20, 2025

Mar 19, 2025

Tvardi Therapeutics Announces Publication of Results from First-in-Human Study of TTI-101 in Patients with Advanced Solid Tumors in the Journal Clinical Cancer Research - The Manila Times

Mar 19, 2025

Mar 19, 2025

Tvardi Therapeutics Announces Publication of Results from - GlobeNewswire

Mar 19, 2025

Mar 18, 2025

Cara Therapeutics, Inc. (NASDAQ:CARA) Receives $27.84 Consensus PT from Analysts - The AM Reporter

Mar 18, 2025

Mar 17, 2025

How to Take Advantage of moves in (CARA) - Stock Traders Daily

Mar 17, 2025

Mar 15, 2025

Cara Therapeutics, Inc. (NASDAQ:CARA) Receives Consensus Rating of “Hold” from Brokerages - Defense World

Mar 15, 2025

Mar 14, 2025

Stamford’s Cara Therapeutics announces layoffs amid operational restructuring - Westfair Online

Mar 14, 2025

Mar 05, 2025

Cara shares jump 32% following reverse stock split - MSN

Mar 05, 2025

Mar 04, 2025

Cara Therapeutics executive Scott Terrillion sells $775 in stock By Investing.com - Investing.com Canada

Mar 04, 2025

Feb 24, 2025

When the Price of (CARA) Talks, People Listen - Stock Traders Daily

Feb 24, 2025

Feb 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders - The Malaysian Reserve

Feb 21, 2025

Feb 20, 2025

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc.CARA - Business Wire

Feb 20, 2025

Feb 19, 2025

Tharimmune (NASDAQ:THAR) and Cara Therapeutics (NASDAQ:CARA) Head-To-Head Review - Armenian Reporter

Feb 19, 2025

Feb 18, 2025

Cara Therapeutics, Inc. (NASDAQ:CARA) Given Average Rating of “Hold” by Brokerages - Defense World

Feb 18, 2025

Feb 17, 2025

Comparing Cara Therapeutics (NASDAQ:CARA) & Tharimmune (NASDAQ:THAR) - Defense World

Feb 17, 2025

Feb 07, 2025

Cara Therapeutics CEO Christopher Posner sells $1,755 in stock By Investing.com - Investing.com South Africa

Feb 07, 2025

Feb 07, 2025

Cara Therapeutics CEO Christopher Posner sells $1,755 in stock - MSN

Feb 07, 2025

Feb 06, 2025

Cara Therapeutics CEO Posner sells shares worth $1,755 By Investing.com - Investing.com Nigeria

Feb 06, 2025